- Hindi news
- National
- Allopathy Medicine Misleading Ads Case; Supreme Court Ayush Ministry | Rule 170
57 minutes ago
- Copy link
The previous hearing had reprimanded the states who did not take action against misleading advertisements.
Allopathy drug misleading advertising case will be heard in the Supreme Court today (March 7). During this time, Chief Secretaries of Delhi, Jammu and Kashmir and Andhra Pradesh will reply in the court for not taking action against misleading medical advertisements.
Earlier on February 10, the Supreme Court had reprimanded the states that did not take action on illegal advertisements of Ayurvedic, Siddha and Unani medicines. Also summoned his Chief Secretary and directed to appear in the next hearing through video conferencing.
At the same time, in this case, on February 24, the court had said- the government should make a system where people can file a complaint of misleading advertisements. The bench will also consider this today.
In the last hearing, the court said- states did not get the order followed
- Earlier on 10 February, Justice Abhay S.K. The bench of Oka and Justice Ujjal Bhuyan had said- Delhi, Andhra Pradesh and Jammu and Kashmir states did not work properly to implement orders. Senior Advocate and Nyaya Mitra (Amicus Curie) Shadhan said- most of the states only accepted apologies and left the rules in writing.
- On this, the bench said- Justice friend has rightly said. If all the state drugs and cosmetics rules, Rule 170 of 1945 are properly implemented, then the problem of illegal advertisements of Ayurvedic, Siddha and Unani medicines will be solved to a large extent. Many orders are not followed even after passing the orders.
- The Supreme Court directed Andhra Pradesh, Delhi, Goa, Gujarat and Jammu and Kashmir to file affidavits. Also asked to file an answer even if Rule 170 is not implemented properly. The court said- We give these states time to file replies by the end of this month.
What is the whole matter In fact, the Supreme Court had banned a notification issued by the Ministry of AYUSH on 27 August 2024, which removed Rule 170 of Drugs and Cosmetics Rules, 1945. This rule prohibits misleading advertisements of Ayurvedic, Siddha and Unani medicines.
The Center issued a letter on August 29, 2023. In this, states and union territories were asked to take any action on companies under Rule 170 or not.
The issue during hearing of Patanjali misleading advertising case picking The issue of Rule 170 was raised during the hearing of Patanjali’s misleading advertising case on 7 May 2024 in the Supreme Court. In fact, the Indian Medical Association (IMA) filed a petition in the Supreme Court on 17 August 2022.
Patanjali, Yoga Guru Ramdev and his colleague Balakrishna have already apologized in the misleading advertising case.
It is accused of making a false claim on Patanjali on covid vaccination, negative publicity against allopathy and the treatment of some diseases from their own Ayurvedic medicines. Also, allopathy has been attacked and claimed to be the treatment of some diseases.
Read this news related to misleading advertisement …
Misleading advertising case- Ramdev apologized in the Supreme Court: The court said- it is not valid; Questions from the government- Why did your eyes be blind
In the misleading advertising case, the Supreme Court on Tuesday gave the last chance to Baba Ramdev and Acharya Balakrishna, managing director of Patanjali Ayurved. The court said that file a week in a week. The next hearing will be held on 10 April. The court said that Ramdev and Balakrishna should be present on the hearing. Read full news …
Leave a Reply